FDA Drug Application (021473) for CIPRO XR by BAYER HLTHCARE

Back to FDA Applications sponsored by BAYER HLTHCARE

Application Number021473
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage212.6MG;EQ 287.5MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCIPRO XR
Active IngredientCIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient CIPROFLOXACIN10
List of drugs with Active Ingredient CIPROFLOXACIN HYDROCHLORIDE9


Back to FDA Applications sponsored by BAYER HLTHCARE